Cancer Research UK publishes Roadmap for the early detection and diagnosis of cancer.
Cancer Research UK publishes its Roadmap for the early detection and diagnosis of cancer. This landmark report sets a shared cross-sectoral vision for a future where no cancer will be detected too late to treat, and outlines a series of tangible recommendations (for research, commercialisation and government policy) to overcome challenges and deliver that future.Read More
Abcodia and AstraZeneca China forge strategic partnership to improve early detection of Ovarian Cancer
Abcodia, a leader in early cancer detection, today announces a strategic partnership with AstraZeneca China, focusing on the early detection of ovarian cancer. With Abcodia’s ROCA Test as the central technology, the parties will collaborate to establish ovarian cancer early detection networks across China. The intent of the collaboration fits strategically with AstraZeneca’s mission to improve cancer outcomes, in support of the Chinese government’s ‘Healthy China 2030’ initiative, which includes a focus on early screening, early diagnosis and early treatment, thus reducing cancer morbidity and mortality and improving the quality of life of patients.Read More
Abcodia partners with Wuxi High-Tech Zone Government
Abcodia, the leader in ovarian cancer early detection, today announces its partnership with the Wuxi National High-Tech Industrial Development Zone (“WND”) supporting Abcodia’s expansion into China. Abcodia will establish offices in the Wuxi International Life Science Innovation Campus (“I·Campus”), which has been created by WND and AstraZeneca. I·Campus is an innovation incubation platform offering services in R&D, commercialization and professional services in the life science industry for domestic and foreign companies looking to establish or expand their presence in China. From this location, Abcodia will work collaboratively with AstraZeneca and other partners in a life science innovative ecosystem to establish its ovarian cancer screening technology in China.Read More
The ROCA Test to be used in a NHS ovarian cancer surveillance service
UCLH Cancer Collaborative has today launched the first pilot project of an NHS ovarian cancer surveillance service for women who carry a faulty BRCA gene and have chosen not to have their ovaries and fallopian tubes removed.Read More